BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32615624)

  • 1. [Indications for Surgery in Pancreatic Ductal Adenocarcinoma - Consensus Recommendations by the German Society for General and Visceral Surgery].
    Belyaev O; Bösch F; Brunner M; Müller-Debus CF; Radulova-Mauersberger O; Wellner UF; Grützmann R; Keck T; Werner J; Witzigmann H; Uhl W
    Zentralbl Chir; 2020 Aug; 145(4):354-364. PubMed ID: 32615624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
    Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
    Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.
    Heinrich S; Besselink M; Moehler M; van Laethem JL; Ducreux M; Grimminger P; Mittler J; Lang H; Lutz MP; Lesurtel M;
    BMC Cancer; 2019 Jul; 19(1):675. PubMed ID: 31288786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
    Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
    Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
    Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
    Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
    World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.
    Boggi U; Kauffmann E; Napoli N; Barreto SG; Besselink MG; Fusai GK; Hackert T; Abu Hilal M; Marchegiani G; Salvia R; Shrikhande SV; Truty M; Werner J; Wolfgang CL; Bannone E; Capretti G; Cattelani A; Coppola A; Cucchetti A; De Sio D; Di Dato A; Di Meo G; Fiorillo C; Gianfaldoni C; Ginesini M; Hidalgo Salinas C; Lai Q; Miccoli M; Montorsi R; Pagnanelli M; Poli A; Ricci C; Sucameli F; Tamburrino D; Viti V; Addeo PF; Alfieri S; Bachellier P; Baiocchi GL; Balzano G; Barbarello L; Brolese A; Busquets J; Butturini G; Caniglia F; Caputo D; Casadei R; Chunhua X; Colangelo E; Coratti A; Costa F; Crafa F; Dalla Valle R; De Carlis L; de Wilde RF; Del Chiaro M; Di Benedetto F; Di Sebastiano P; Dokmak S; Hogg M; Egorov VI; Ercolani G; Ettorre GM; Falconi M; Ferrari G; Ferrero A; Filauro M; Giardino A; Grazi GL; Gruttadauria S; Izbicki JR; Jovine E; Katz M; Keck T; Khatkov I; Kiguchi G; Kooby D; Lang H; Lombardo C; Malleo G; Massani M; Mazzaferro V; Memeo R; Miao Y; Mishima K; Molino C; Nagakawa Y; Nakamura M; Nardo B; Panaro F; Pasquali C; Perrone V; Rangelova E; Liu R; Romagnoli R; Romito R; Rosso E; Schulick R; Siriwardena A; Spampinato MG; Strobel O; Testini M; Troisi RI; Uzunoglo FG; Valente R; Veneroni L; Zerbi A; Vicente E; Vistoli F; Vivarelli M; Wakabayashi G; Zanus G; Zureikat A; Zyromski NJ; Coppola R; D'Andrea V; Davide J; Dervenis C; Frigerio I; Konlon KC; Michelassi F; Montorsi M; Nealon W; Portolani N; Sousa Silva D; Bozzi G; Ferrari V; Trivella MG; Cameron J; Clavien PA; Asbun HJ;
    Ann Surg; 2024 Jul; 280(1):56-65. PubMed ID: 38407228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline resectable pancreatic cancer.
    Hackert T; Ulrich A; Büchler MW
    Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines.
    Dhayat SA; Mirgorod P; Lenschow C; Senninger N; Anthoni C; Vowinkel T
    PLoS One; 2017; 12(3):e0173374. PubMed ID: 28267771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.
    Kim JK; DePeralta DK; Ogami T; Denbo JW; Pimiento J; Hodul PJ; Malafa MP; Kim DW; Fleming JB; Powers BD
    J Surg Oncol; 2020 Nov; 122(6):1074-1083. PubMed ID: 32673436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
    Honselmann KC; Elser Y; Boeckmann T; Bolm L; Winkel MT; Deichmann S; Braun R; Wellner UF; Keck T; Lapshyn H
    Surgery; 2023 Sep; 174(3):674-683. PubMed ID: 37349251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
    Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
    BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease.
    Dima SO; Dumitraşcu T; Popescu I; Duda DG
    Chirurgia (Bucur); 2022 Jun; 117(4):407-414. PubMed ID: 36049097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
    Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP
    Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese expert consensus on minimally invasive radical surgery for pancreatic ductal adenocarcinoma (version 2022)].
    ;
    Zhonghua Wai Ke Za Zhi; 2023 Mar; 61(3):187-195. PubMed ID: 36650963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
    Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
    Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
    Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
    BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.